美国人类乳头瘤病毒疫苗接种的最新进展。
An Update on Human Papillomavirus Vaccination in the United States.
机构信息
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, O'Neal Comprehensive Cancer Center, and the Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Alabama.
出版信息
Obstet Gynecol. 2023 Feb 1;141(2):324-330. doi: 10.1097/AOG.0000000000005056. Epub 2023 Jan 4.
Abstract
Cervical cancer remains a significant disease in the United States. Although the human papillomavirus (HPV) vaccine has been approved for those aged 9-26 years and for some individuals up to age 45 years, there are many circumstances in which health care professionals may not know whether the vaccine should be recommended, such as for patients with previous infection, health care workers, and those older than age 26 years. This article highlights the evidence that the HPV vaccine is a safe and highly effective way to prevent cervical cancer, with the strongest predictor of vaccine uptake being practitioner recommendation.
摘要
宫颈癌仍然是美国的一个重大疾病。尽管人乳头瘤病毒（HPV）疫苗已获准用于 9-26 岁人群，并且某些人可接种至 45 岁，但在许多情况下，医疗保健专业人员可能不知道是否应推荐接种疫苗，例如对于曾经感染过的患者、医护人员以及年龄超过 26 岁的人群。本文重点介绍了 HPV 疫苗是预防宫颈癌的安全且高效的方法的证据，疫苗接种率的最强预测因素是医生的推荐。
相似文献
1
An Update on Human Papillomavirus Vaccination in the United States.美国人类乳头瘤病毒疫苗接种的最新进展。
Obstet Gynecol. 2023 Feb 1;141(2):324-330. doi: 10.1097/AOG.0000000000005056. Epub 2023 Jan 4.
2
Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.宫颈癌及相关宫颈疾病的预防：致癌性人乳头瘤病毒（HPV）疫苗接种的成本效益综述
J Manag Care Pharm. 2010 Apr;16(3):217-30. doi: 10.18553/jmcp.2010.16.3.217.
3
Human Papillomavirus Vaccine: The Cancer Prevention Moonshot.人乳头瘤病毒疫苗：癌症预防的登月计划。
Obstet Gynecol Clin North Am. 2023 Jun;50(2):339-348. doi: 10.1016/j.ogc.2023.02.006. Epub 2023 Apr 2.
4
Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012.医疗服务提供者对人乳头瘤病毒（HPV）疫苗预防癌症有效性的看法及其推荐的疫苗接种年龄组：2012年医疗服务提供者调查结果
Prev Med. 2015 Dec;81:405-11. doi: 10.1016/j.ypmed.2015.10.007. Epub 2015 Oct 24.
5
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).四价人乳头瘤病毒疫苗：免疫实践咨询委员会（ACIP）的建议
MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24.
6
HPV Vaccination Hesitancy Among Latina Immigrant Mothers Despite Physician Recommendation.尽管医生建议，拉美裔移民母亲对 HPV 疫苗仍犹豫不决。
Ethn Dis. 2020 Sep 24;30(4):661-670. doi: 10.18865/ed.30.4.661. eCollection 2020 Fall.
7
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.接种人乳头瘤病毒预防性疫苗以预防宫颈癌及其癌前病变。
Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.
8
Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.家长对埃塞俄比亚德布雷塔博镇女童 HPV 疫苗接种的知识和意愿：一项基于社区的横断面研究。
Reprod Health. 2022 Jun 10;19(1):136. doi: 10.1186/s12978-022-01444-4.
9
Single-dose human papillomavirus vaccination: an update.单剂人乳头瘤病毒疫苗接种：更新。
J Natl Cancer Inst Monogr. 2024 Nov 1;2024(67):313-316. doi: 10.1093/jncimonographs/lgae030.
10
Cancer Prevention Begins in Middle School: The Personal Advantages of HPV Immunization in Males.癌症预防始于中学：男性接种人乳头瘤病毒疫苗的个人益处。
NASN Sch Nurse. 2023 May;38(3):114-120. doi: 10.1177/1942602X221151134. Epub 2023 Jan 23.
引用本文的文献
1
Attitudes toward an HPV vaccine for condyloma acuminata and willingness to undergo vaccination among STD clinic attendees in China: Focus on STI prevention with HPV vaccine.中国人对预防性 HPV 疫苗（针对尖锐湿疣）的态度和接种意愿：关注 HPV 疫苗在性病预防中的应用。
BMC Public Health. 2024 Jun 17;24(1):1610. doi: 10.1186/s12889-024-18904-0.
2
Opportunities for cancer prevention at syringe services programs: acceptability of HPV self-sampling and vaccination among people who inject drugs. syringe 服务项目中的癌症预防机会：注射毒品者对 HPV 自我采样和疫苗接种的可接受性。
Harm Reduct J. 2024 Mar 27;21(1):70. doi: 10.1186/s12954-024-00982-3.
3
New Paradigms in the Treatment of Cervical Cancer.宫颈癌治疗的新范式。
Obstet Gynecol. 2023 Dec 1;142(6):1322-1332. doi: 10.1097/AOG.0000000000005413. Epub 2023 Oct 12.
4
EDA-E7 Activated DCs Induces Cytotoxic T Lymphocyte Immune Responses against HPV Expressing Cervical Cancer in Human Setting.EDA-E7激活的树突状细胞在人体环境中诱导针对表达人乳头瘤病毒的宫颈癌的细胞毒性T淋巴细胞免疫反应。
Vaccines (Basel). 2023 Jan 31;11(2):320. doi: 10.3390/vaccines11020320.
本文引用的文献
1
One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer.一剂人乳头瘤病毒（HPV）疫苗可为预防宫颈癌提供可靠的保护。
Saudi Med J. 2022 May;43(5):538.
2
HPV Vaccination after Primary Treatment of HPV-Related Disease across Different Organ Sites: A Multidisciplinary Comprehensive Review and Meta-Analysis.不同器官部位HPV相关疾病初次治疗后的HPV疫苗接种：多学科综合综述与荟萃分析
Vaccines (Basel). 2022 Feb 4;10(2):239. doi: 10.3390/vaccines10020239.
3
Human papillomavirus dose reminder preferences among parents from a diverse clinical sample: a qualitative study.HPV 疫苗剂量提醒偏好的多样性临床样本的父母：一项定性研究。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2031697. doi: 10.1080/21645515.2022.2031697. Epub 2022 Feb 18.
4
Beyond words: Parental perceptions on human papilloma virus vaccination recommendations and its impact on uptake.难以言表：父母对人乳头瘤病毒疫苗接种建议的看法及其对接种率的影响
Prev Med Rep. 2021 Oct 11;24:101596. doi: 10.1016/j.pmedr.2021.101596. eCollection 2021 Dec.
5
Single-dose HPV vaccination efficacy among adolescent girls and young women in Kenya (the KEN SHE Study): study protocol for a randomized controlled trial.肯尼亚青少年女孩和年轻女性中单次 HPV 疫苗接种的效果（KEN SHE 研究）：一项随机对照试验的研究方案。
Trials. 2021 Sep 27;22(1):661. doi: 10.1186/s13063-021-05608-8.
6
The role of trust in HPV vaccine uptake among racial and ethnic minorities in the United States: a narrative review.信任在美国少数族裔人乳头瘤病毒疫苗接种中的作用：一项叙述性综述
AIMS Public Health. 2021 Apr 6;8(2):352-368. doi: 10.3934/publichealth.2021027. eCollection 2021.
7
Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis.美国 30 至 45 岁成人接种人乳头瘤病毒疫苗的成本效益分析。
PLoS Med. 2021 Mar 11;18(3):e1003534. doi: 10.1371/journal.pmed.1003534. eCollection 2021 Mar.
8
HPV Vaccination and the Risk of Invasive Cervical Cancer.HPV 疫苗接种与浸润性宫颈癌风险。
N Engl J Med. 2020 Oct 1;383(14):1340-1348. doi: 10.1056/NEJMoa1917338.
9
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019.2019 年美国 13-17 岁青少年的国家、地区、州和选定局部地区疫苗接种覆盖率。
MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1109-1116. doi: 10.15585/mmwr.mm6933a1.
10
HPV Vaccination as Adjuvant to Conization in Women with Cervical Intraepithelial Neoplasia: A Study under Real-Life Conditions.人乳头瘤病毒疫苗作为宫颈上皮内瘤变女性锥切术的辅助治疗：一项真实生活条件下的研究
Vaccines (Basel). 2020 May 23;8(2):245. doi: 10.3390/vaccines8020245.
Zotero 插件